Prof. Avner Yayon, Ph.D., M.D.
President and Chairman
Prof. Yayon is a pioneer and world-renown researcher in polypeptide growth factors, the extracellular matrix and the mechanisms underlying human skeletal disorders. He was the scientific founder of ProChon Biotech Ltd. and served as its President and CSO since 1996. ProChon developed an advanced cartilage repair product, BioCart™II and was later acquired by Histogenics. Prof. Yayon holds a Ph.D. and M.D. from the Hebrew University and Hadassah Medical School of Jerusalem. He served as a Research Associate in the department of surgical research at Harvard Medical School, and as Associate Professor of Molecular Cell Biology at the Weizmann Institute of Science.
Shimon Yurman M.B.A
Chief Executive Officer
Shimon is bringing more than 23 years of experience in commerce, sales and marketing, business development, manufacturing and logistics, with more than 15 years of experience as a high-level manager.
Specialties: Highly motivated business leader who brings together broad strategic, managerial, commercial, marketing, sales skills and business understanding combined with the highest interpersonal skills that drives for best execution results.
Shimon holds an M.B.A. from IDC Herzliya and B.A in Economics & Business Administration from Bar Ilan University.
Eran Ovadya, M.B.A
Chief Finance Officer
Eran has more than 15 years of experience in Biotech and Medical Device industries with a professional track record from 1 st tier global corporations. Eran is a dynamic, innovative results oriented leader with diverse multinational experience, as of Finance Director and CFO in a privately held companies, IPOs, Public area, and Global Corporates. Eran has a strong track record of performance in highly competitive environments Great interpersonal skills, and motivating staff (HR, Finance, Legal, Operation and IT) to peak performance. Eran holds an M.B.A in Business Management from the Open University and B.A in Economics and Accounting from the Open University.
Tamar Auerbach, Ph.D
VP Research & Development
Tamar has over 15 years of experience in the biotech sector. Prior to joining Procore, she served in various biotech companies, managing multidisciplinary teams. She was focused on research and development and managed to gain extensive knowledge in the development of pharmaceuticals and innovative medical devices over the years. Further Tamar is experienced in a varied field, including protein analytics, project management, production processes, quality, pre-clinical, regulatory and clinical operations.
Tamar holds a Ph.D. in Biochemistry from the lab of Prof. Ada Yonath.
Orit Pollack-Shragai, M.Sc., M.B.A
Director of Clinical Operations
Orit joined Procore in 2018 bringing over two decades of experience in the biomedical field, both in academia and industry. Prior to joining Procore Orit served as a CRA, Project Manager and Clinical Research Manager including project management of international clinical trials at a leading CRO firm. Orit holds a B.Sc. in Food Engineering and Biotechnology from the Technion-Israel Institute of Technology’s Food and Biotechnology Engineering Faculty, a M.Sc. in Biotechnology from the Hebrew University of Jerusalem and an MBA from the College of Management Academic Studies.
Eilat Bain Ph.D., M.D.
Production & Operation Manager
Eilat is a seasoned biotech professional and has extensive experience in product development and operations, transfer of technology and production to sites in the U.S. and Europe for clinical trials and manufacturing. Prior to joining Procore, Eilat served as Director of Operations at Hemostemix Ltd. and before that led the cell therapy unit at Macrocure Ltd. and Theravitae Ltd. Eilat holds a B.Sc. in Biology from the Hebrew University of Jerusalem.